http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1000505-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e847ba056c00fe5c2619d20924ffa76b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
filingDate 1961-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1965-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1000505-A
titleOfInvention 2-(ª‡-oxo-aralkyl)benzimidazole compounds, and process of making same
abstract The invention comprises compounds of the formula <FORM:1000505/C2/1> and their pharmaceutically acceptable acid addition salts, wherein R is a dialkylamino alkyl, monoalkylamino alkyl, hydroxy alkyl, piperidino alkyl, or morpholino alkyl group. R1 is an aralkyl group of the formula <FORM:1000505/C2/2> <FORM:1000505/C2/3> wherein n is 0 or an integer from 1 to 4, m is an integer from 1 to 4 and R2 to R6 are hydrogen or halogen atoms or alkoxy, nitro, amino, monoalkylamino, dialkylamino, monoacylamino or C1- 5-alkyl groups, and the preparation thereof either by reacting a compound of the formula <FORM:1000505/C2/4> with an alkyl halide R-Hal in the presence of agents capable of splitting off and binding hydrogen halide; or by reacting a compound of the general formula <FORM:1000505/C2/5> with agents capable of oxidizing a secondary alcohol group to a keto group; or by reacting a compound of the general formula <FORM:1000505/C2/6> wherein R8 is halogeno alkyl, with a mono- or dialkyl-amine, piperidine or morpholine. 2 - a - Hydroxybenzimidazoles are prepared from an N-substituted or -unsubstituted o-phenylene diamine and an appropriate mandelic acid or its imino ether. 2 - a - Ketobenzimidazoles of Formula V are prepared by oxidation of the corresponding 2-a -hydroxybenzimidazole with selenium dioxide. Benzimidazoles of Formula VI are prepared from the corresponding 1-hydroxy alkyl derivatives by halogenation. 4-Methoxy phenyl lactic acid nitrile is prepared from anisaldehyde and monochloroacetic acid to form the 4-methoxyphenylacetaldehyde and reacting the bisulphite with a cyanide. The nitrile is converted into the imino ether. Pharmaceutical compositions, having analgesic and spasmolytic activity, contain the compounds of the invention and may be formulated as tablets, pills, dragees, capsules, suppositories and solutions for parenteral administration.
priorityDate 1960-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414635703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411860674
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408599808
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457472442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424570953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8082

Total number of triples: 34.